We serve 2-(Chloromethyl)-3,4-dimethoxypyridine Hydrochloride CAS:72830-09-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-(Chloromethyl)-3,4-dimethoxypyridine Hydrochloride
CAS.NO: 72830-09-2
Synonyms:
2-Chloromethyl-3,4-dimethoxypyridinium chloride
Molecular Formula: C8H11Cl2NO2
Molecular Weight:224.08400
Physical and Chemical Properties:
Density: /
Boiling point:293.9ºC at 760 mmHg
Melting point:155 °C (dec.)(lit.)
Flash point: 131.6ºC
Refractive index: /
Specification:
Appearance:Light yellow to off white powder
Purity:≥98%
Chloride(Cl):≤0.05%
Sulfate(SO4):≤0.03%
Iron(Fe):≤0.003%
Heavy Metals:≤0.0015%
Loss on drying:≤0.5%
Residue on Ignition:≤0.3%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Pantoprazole CAS:102625-70-7
Contact us for information like 2-(Chloromethyl)-3,4-dimethoxypyridine Hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloromethyl-3,4-dimethoxypyridinium chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Chloromethyl)-3,4-dimethoxypyridine Hydrochloride Use and application,2-Chloromethyl-3,4-dimethoxypyridinium chloride technical grade,usp/ep/jp grade.
Related News: Indonesia is suspending its visa-free travel for Chinese citizens and barring passengers who have visited mainland China in the past 14 days.3-chlorophenol manufacturer The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.4-tert-Butylbenzylamine supplier There’s a few factors that play into this.4-(trifluoromethyl)phenol vendor Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.
